Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles.

Flow imaging Gravity infusion Infusion pump Peristaltic pump Protein aggregation Subvisible particle

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Jul 2023
Historique:
received: 26 01 2023
revised: 12 05 2023
accepted: 25 05 2023
medline: 24 7 2023
pubmed: 3 6 2023
entrez: 2 6 2023
Statut: ppublish

Résumé

Subvisible particles generated during the preparation or administration of biopharmaceuticals might increase the risk of immunogenicity, inflammation, or organ dysfunction. To investigate the impact of an infusion system on the level of subvisible particles, we compared two types of infusion sets based on peristaltic movement (Medifusion DI-2000 pump) and a gravity-based infusion system (Accu-Drip) using intravenous immunoglobulin (IVIG) as a model drug. The peristaltic pump was found to be more susceptible to particle generation compared to the gravity infusion set owing to the stress generated due to constant peristaltic motion. Moreover, the 5-µm in-line filter integrated into the tubing of the gravity-based infusion set further contributed to the reduction of particles mostly in the range ≥ 10 µm. Furthermore, the filter was also able to maintain the particle level even after the pre-exposure of samples to silicone oil-lubricated syringes, drop shock, or agitation. Overall, this study suggests the need for the selection of an appropriate infusion set equipped with an in-line filter based on the sensitivity of the product.

Identifiants

pubmed: 37268032
pii: S0378-5173(23)00511-2
doi: 10.1016/j.ijpharm.2023.123091
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0
Silicone Oils 0
Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123091

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Shavron Hada (S)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: shavron.hada@dgu.ac.kr.

Sunkyong Ji (S)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: jisunk97@dongguk.edu.

Ye Na Lee (YN)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: scht35@dgu.ac.kr.

Ki Hyun Kim (KH)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: kihyun@dongguk.edu.

Ravi Maharjan (R)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: raavii@dgu.ac.kr.

Nam Ah Kim (NA)

College of Pharmacy, Mokpo National University, Jeonnam 58554, Republic of Korea. Electronic address: namahk87@mnu.ac.kr.

Jukka Rantanen (J)

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark. Electronic address: jukka.rantanen@sund.ku.dk.

Seong Hoon Jeong (SH)

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea. Electronic address: shjeong@dongguk.edu.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Humans Infusions, Intravenous Immune Checkpoint Inhibitors Infusion Pumps Elastomers
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female

Classifications MeSH